MedPath

珠海联邦制药股份有限公司

Ownership
-
Established
1993-07-03
Employees
-
Market Cap
-
Website
www.tul.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

59

NMPA:59

Drug Approvals

Tazobactam

Product Name
他唑巴坦
Approval Number
国药准字H19990183
Approval Date
May 14, 2024
NMPA

Amoxicillin

Product Name
阿莫西林
Approval Number
国药准字H44023994
Approval Date
May 14, 2024
NMPA

Amoxicillin Sodium and Clavulanate Potassium

Product Name
阿莫西林钠克拉维酸钾
Approval Number
国药准字H20058469
Approval Date
May 14, 2024
NMPA

Ampicillin Sodium

Product Name
氨苄西林钠
Approval Number
国药准字H20063458
Approval Date
Apr 26, 2024
NMPA

Triprolidine Hydrochloride

Product Name
盐酸曲普利啶
Approval Number
国药准字H20010627
Approval Date
Apr 26, 2024
NMPA

Ampicillin

Product Name
氨苄西林
Approval Number
国药准字H44023995
Approval Date
Apr 26, 2024
NMPA

Biapenem for Injection

Product Name
注射用比阿培南
Approval Number
国药准字H20140075
Approval Date
Dec 18, 2023
NMPA

Ceftazidime

Product Name
头孢他啶
Approval Number
国药准字H20023598
Approval Date
Dec 18, 2023
NMPA

Cefradine

Product Name
头孢拉定
Approval Number
国药准字H20003799
Approval Date
Dec 18, 2023
NMPA

Cefotaxime Sodium

Product Name
头孢噻肟钠
Approval Number
国药准字H19983226
Approval Date
Dec 18, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.